References
Gondim FAA, Filha JGH, Jordanova A (2020) Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report. Acta Neurol Belg 120:201–203
Planté-Bordeneuve V, Ferreira A, Lalu T et al (2007) Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 69:693–698
Cortese A, Vegezzi E, Lozza A et al (2017) Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry 88:457–458
Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM (2012) Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 45:26–31
Rajabally YA, Admas D, Latour P, Attarian S (2016) Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. J Neurol Neurosurg Psychiatry 87:1051–1060
Van den Bergh PY, Hadden RD, Bouche P et al (2010) European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society—first revision. Eur J Neurol 17:356–363
Conceição I, Miranda B, Castro J, de Carvalho M (2018) Hereditary amyloidosis related to transthyretin V30M: disease progression in treated and untreated patients. Eur J Neurol 25:1320-e115
Martens B, Pauw MD, Bleecker JLD (2018) Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review. Acta Neurol Belg 118:179–185
Acknowledgements
This study was supported (student scholarship) by UFPR. Genetic analysis (TTR gene) was supported by Pfizer. The laboratory team of the Mendelics (São Paulo) for their collaboration in the genetic analysis.
Funding
This study was supported (student scholarship) by UFPR. Genetic analysis (TTR gene) was supported by Pfizer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
The study was approved by the Local Ethics Committee for Human Research.
Informed consent
All studies were conducted in accordance with ethical principles after obtaining patient consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lorenzoni, P.J., Giugno, V.R., Ducci, R.DP. et al. Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid. Acta Neurol Belg 123, 1655–1657 (2023). https://doi.org/10.1007/s13760-023-02215-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-023-02215-z